“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients

ORIGINAL RESEARCH ARTICLE

“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients"

Kiriakos Koukoulias, Penelope-Georgia Papayanni, Aphrodite Georgakopoulou, Maria Alvanou, Stamatia Laidou, Anastasios Kouimtzidis, Chrysoula Pantazi, Glykeria Gkoliou, Timoleon-Achilleas Vyzantiadis, Alexandros Spyridonidis, Antonios Makris, Anastasia Chatzidimitriou, Nikoletta Psatha, Achilles Anagnostopoulos, Evangelia Yannaki and Anastasia Papadopoulou


Front. Immunol., 18 January 2021

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Neuenhahn M, Albrecht J, Odendahl M, Schlott F, Dössinger G, Schiemann M, Lakshmipathi S, Martin K, Bunjes D, Harsdorf S, Weissinger EM, Menzel H, Verbeek M, Uharek L, Kröger N, Wagner E, Kobbe G, Schroeder T, Schmitt M, Held G, Herr W, Germeroth L, Bonig H, Tonn T, Einsele H, Busch DH, Grigoleit GU. Leukemia.2017 Feb 17.doi: 10.1038/leu.2017.16. [Epub ahead of print]